STATE PHARMACEUTICALS CORPORATION — Heparin Importer Profile
Pharmaceutical Importer · #14 buyer for Heparin · $500.0K import value · 10 shipments · SRI LANKA · DGFT Verified
STATE PHARMACEUTICALS CORPORATION is the #14 importer of Heparin from India with $500.0K in import value and 10 verified shipments. STATE PHARMACEUTICALS CORPORATION holds a 0.1% market share in Heparin imports based in SRI LANKA. The company sources from 1 verified supplier across 5 formulations shipped to 1 country. Overall, STATE PHARMACEUTICALS CORPORATION imports 14 pharmaceutical products worth $4.2M across 8 therapeutic categories.
STATE PHARMACEUTICALS CORPORATION — Heparin Import Profile: Suppliers, Formulations & Sources

Who Actually Supplies Heparin to STATE PHARMACEUTICALS CORPORATION?
Verified from 10 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| GLAND PHARMA LIMITED | $500.0K | 10 | 100.0% |
STATE PHARMACEUTICALS CORPORATION sources Heparin from 1 verified Indian supplier based on 10 customs records. The primary supplier is GLAND PHARMA LIMITED accounting for 100.0% of imports.
Where Does STATE PHARMACEUTICALS CORPORATION Import Heparin To?
Destination countries from 10 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| SRI LANKA | $500.0K | 10 | 100.0% |
STATE PHARMACEUTICALS CORPORATION imports Heparin to 1 country. The primary destination is SRI LANKA receiving 100.0% of shipments worth $500.0K.
What Heparin Formulations Does STATE PHARMACEUTICALS CORPORATION Import?
| Formulation | Value | Shipments |
|---|---|---|
| LOW MOLECULAR WEIGHT HEPARIN ENOXAPARIN | $150.0K | 3 |
| LOW MOLECULAR WEIGHTHEPARIN ENOXAPARIN SODIUM INJECTION USP 60MG IN 0 6MLPRE FILLED SYRINGE | $100.0K | 2 |
| LOW MOLECULAR WEIGHTHEPARIN ENOXAPARINSODIUM INJECTION USP 60MG IN 0 6MLPRE FILLED SYRINGE | $100.0K | 2 |
| HEPARIN INJECTION BP5000IU/ML-5ML VIALSH | $100.0K | 2 |
| LOW MOLECULAR WEIGHTHEPARIN ENOXAPARINSO | $50.0K | 1 |
STATE PHARMACEUTICALS CORPORATION imports 5 distinct Heparin formulations from India. The top formulation is LOW MOLECULAR WEIGHT HEPARIN ENOXAPARIN with 3 shipments worth $150.0K.
Who Are the Top Buyers of Heparin from India and How Much Does STATE PHARMACEUTICALS CORPORATION Import?
India exported $68.4M worth of Heparin through 4,586 shipments from 391 suppliers to 137 countries, serving 854 buyers globally. STATE PHARMACEUTICALS CORPORATION imports $500.0K of this total, accounting for 0.1% of India's Heparin exports with 10 shipments from SRI LANKA. This is verified from 10 customs shipment records covering 5 distinct formulations.
What Is the Average Order Value for STATE PHARMACEUTICALS CORPORATION's Heparin Imports?
STATE PHARMACEUTICALS CORPORATION's average Heparin order value is $50.0K per consignment, based on 10 shipments totaling $500.0K. STATE PHARMACEUTICALS CORPORATION is based in SRI LANKA and ranks #14 among all Heparin importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Heparin to STATE PHARMACEUTICALS CORPORATION?
STATE PHARMACEUTICALS CORPORATION sources Heparin from 1 verified Indian supplier: GLAND PHARMA LIMITED ($500.0K, 100.0%). This is based on 10 customs records.
How Does STATE PHARMACEUTICALS CORPORATION Compare to Other Heparin Importers?
STATE PHARMACEUTICALS CORPORATION ranks #14 among 854 Heparin importers from India with a 0.1% market share. The top 3 importers are FRESENIUS KABI USA, LLC ($19.4M), EVERSANA ($13.4M), BOSTON ONCOLOGY ARABIA ($11.2M). STATE PHARMACEUTICALS CORPORATION processed 10 shipments from SRI LANKA.
What Other Cardiovascular Products Does STATE PHARMACEUTICALS CORPORATION Import?
STATE PHARMACEUTICALS CORPORATION also imports these cardiovascular products. Each links to the detailed product page.
About STATE PHARMACEUTICALS CORPORATION
STATE PHARMACEUTICALS CORPORATION imports 14 products worth $4.2M. Beyond Heparin, top products include Immunoglobulin, Enoxaparin, Morphine, Sitagliptin, Rituximab. View the complete STATE PHARMACEUTICALS CORPORATION profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Heparin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Heparin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: STATE PHARMACEUTICALS CORPORATION matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as STATE PHARMACEUTICALS CORPORATION's capped import value divided by total capped export value for Heparin across all Indian exporters.
- 5.Verified Records: This page is backed by 10 individual customs records matching STATE PHARMACEUTICALS CORPORATION importing Heparin, covering 5 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 137+ countries, 854+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Heparin Import Data for STATE PHARMACEUTICALS CORPORATION
Access order-level details, pricing data, supplier connections, and competitive analysis for STATE PHARMACEUTICALS CORPORATION's Heparin imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
STATE PHARMACEUTICALS CORPORATION
Full Company Profile →
14 products · $4.2M total trade · 8 categories
STATE PHARMACEUTICALS CORPORATION × Heparin
Verified from customs records
Company Overview
Top Products by STATE PHARMACEUTICALS CORPORATION
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for STATE PHARMACEUTICALS CORPORATION.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Heparin. For current order-level data, contact TransData Nexus.